Thrombin-specific Anticoagulant Bivalirudin During Percutaneous Coronary Intervention (PCI) Clinical Trial
Official title:
European Registry of Consecutive Patients Undergoing PCI Evaluating the Use of the Thrombin-specific Anticoagulant Bivalirudin With Focus on Patient Selection, Convenience and Safety Aspects.
The objectives of this registry are to assess the use of the thrombin-specific anticoagulant
bivalirudin during percutaneous coronary intervention (PCI) in a real life setting. In
particular, data will be collected to analyze experiences of bivalirudin use in respect to
the following objectives;
- examine the aspects of safety and effectiveness of bivalirudin
- gain experience regarding the characteristics of patients in bivalirudin treatment
- evaluate the handling of bivalirudin and its practicality
n/a
Observational Model: Cohort, Time Perspective: Retrospective